Journal of the American Chemical Society · 1997 · 317 citations · 27 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructural BiologyStructure-activity RelationshipsEnzyme InhibitionHit-to-lead OptimizationLead DiscoveryLigand BindingPotency OptimizationStructure-activity Relationship AnalysisFragment OptimizationLead Enzyme DiscoveryMolecular Property OptimizationNuclear Magnetic Resonance Studies
With the use of an NMR-based method, potent (IC 50 < 25 nM) nonpeptide inhibitors of the matrix metalloproteinase stromelysin (MMP-3) were discovered. The method, called SAR by NMR (for structure−activity relationships by nuclear magnetic resonance), involves the identification, optimization, and linking of compounds that bind to proximal sites on a protein. Using this technique, two ligands that bind weakly to stromelysin (acetohydroxamic acid, K D = 17 mM; 3-(cyanomethyl)-4‘-hydroxybiphenyl, K D = 0.02 mM) were identified. On the basis of NMR-derived structural information, the two fragments were connected to produce a 15 nM inhibitor of this enzyme. This compound was rapidly discovered (less than 6 months) and required only a minimal amount of chemical synthesis. These studies indicate that the SAR by NMR method can be effectively applied to enzymes to yield potent lead inhibitors an important part of the drug discovery process.
27
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Suzanne B. Shuker, Philip J. Hajduk, Robert Meadows et al. · Science · 1996 · 2K citations
Michaël Nilges, G. Marius Clore, Angela M. Gronenborn · FEBS Letters · 1988 · 768 citations · Full text